UNITED THERAPEUTICS Corp - Common Stock (UTHR)

CUSIP: 91307C102

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class
Equity / Common Stock
Total 13F shares
41,674,368
Total 13F value
$20,284,637,524
Holder snapshot 6 visible 7 signals
Share change
+767,154
Put/Call ratio
91%
SEC-reported price per share
$487.25
Number of holders
832
Value change
+$459,092,354
Number of buys
435
Open additional details 1 more signal available
Number of sells
312
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
43,898,805

Security key

91307C102

Report period

Q4 2025

Institutions

832

Top holders

10

UTHR full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 UNITED THERAPEUTICS Corp SEC filings UNITED THERAPEUTICS Corp company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F Lead comparable stake: 5.7% 13D/G row: WELLINGTON MANAGEMENT GROUP LLP Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 5.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Comparable ownership Top 5
WELLINGTON MANAGEMENT GROUP LLP 5.7%
STATE STREET CORP 4.9%
BlackRock, Inc. 12%
VANGUARD GROUP INC 10%
RENAISSANCE TECHNOLOGIES LLC 5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13D/G 13F
Company
13D/G 13F
5.7%
$1,189,616,977
2,441,492 shares
 +$202,245,781 31 Dec 2025
STATE STREET CORP
13F 13D/G
Company · STATE STREET CORPORATION
13F 13D/G
4.9%
from 13D/G
$805,976,919
1,922,609 shares
 — 30 Sep 2025
BlackRock, Inc.
13F
Company
13F
12%
$2,244,029,549
5,352,996 shares
 — 30 Sep 2025
VANGUARD GROUP INC
13F
Company
13F
10%
$1,852,325,498
4,418,610 shares
 — 30 Sep 2025
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
5%
$911,107,660
2,173,392 shares
 — 30 Sep 2025
Avoro Capital Advisors LLC
13F
Company
13F
4.6%
$847,735,685
2,022,222 shares
 — 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
832
Shares
41,674,368
Rows available
832
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
701
Q4 2025 holders
832
Holder diff
131
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .